Stockreport

GENFIT Reports Full-Year 2019 Financial Results and Corporate Update

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 3 [Read more]